The Risk of Malignancy Index (RMI) in Diagnosis of Ovarian Malignancy

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 5, 2009, Pages 865-868

  Moolthiya, Watcharada ^a   Yuenyao, Pissamai ^a  

^a Srinagarind hospital   (Thailand)

Author keywords

Menopausal status; Ovarian tumou; Risk of malignancy index; Serum CA 125; Ultrasonographic score

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; ARTICLE; BLOOD; CANCER STAGING; COLLOID CARCINOMA; CYSTADENOCARCINOMA; ECHOGRAPHY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOLOGY; MIDDLE AGED; OVARY TUMOR; POSTMENOPAUSE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; CA-125 ANTIGEN; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSTMENOPAUSE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY;

EID: 77952306271     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Benjapibal M, Neungton C (2007). Pre-operative prediction of serum CA 125 level in women with ovarian masses. J Med Assoc Thai, 90, 1986-91.
2. Davies AP, Jacob I, Woolas R, et al (1993). The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol, 100, 927-931.
3. Ferrazzi E, Zanetta G, Dordoni D, et al (1997). Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study. Ultrasound Obstet Gynecol, 10, 192-7.
4. Granberg S, Norstrom A, Wikland M (1990). Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol, 37, 224-9.
5. Jacobs I, Oram D, Fairbanks J, et al (1990). A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate pre-operative diagnosis of ovarian cancer. Br J Obstet Gynaecol, 97, 922-9.
6. Leelahakorn S, Tangjitgamol S, Manusirivithaya, et al (2005). Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors. J Med Assoc Thai, 88, 22-30.
7. Morgante G, la Marca A, Ditto A, et al (1999). Comparison of two malignancy indices based on serum CA 125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynaecol, 106, 524-7.
8. Obeidat BR, Amarin ZO, Latimer JA, et al (2004). Risk of malignancy index in the preoperative evaluation of pelvic masses. Int J Gynaecol Obstet, 85, 255-8.
9. Sassone AM, Timor-Tritsch IE, Artner A, et al (1991). Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol, 78, 70-6.
10. Soegaard R, Knudsen A, Rix P, et al (2003). Risk of malignancy Index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol, 90, 109-12.
11. Tingulstad S, Hagen B, Skjeldestad FE, et al (1996). Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the preoperative diagnosis of pelvic masses. Br J Obstet Gynaecol, 103, 826-31.
12. Ulusoy S, Akbayir O, Numanoglu C, et al (2007). The risk of malignancy index in discrimination of adnexal masses. Int J Gynaecol Obstet, 96, 186-91.